Comprehend Releases New Version of Clinical Intelligence Suite
DIA 2017 Booth #1340, Chicago, June 19, 2017 - Comprehend Systems, Inc. announced the newest version of its Clinical Intelligence Suite. The new version includes additional functionality to manage evolving study conduct data.
“We’re excited to deliver this functionality in our Clinical Intelligence Suite to help end-users easily design and implement visualizations based on their specific need, with drill-down, drag-and-drop analytics and on-the-fly reporting,” said Rick Morrison, CEO. “Clinical Operations teams will benefit from increased productivity, access to universal data, speed to results, and better optimization of resources.”
In Booth #1340 at DIA 2017, Comprehend’s Clinical Intelligence experts will demonstrate the new software and discuss customer case studies in:
- Real-time Quality Agreements and Oversight Plans with CRO, KPI, and Site scorecards
- Personalized dashboards with drag and drop analytics to create compelling
- portfolio, study, and CRO views
- Self-service reporting with creation of interactive visualizations-no coding required
- Accelerated medical data review with dynamic line listings and graphical patient profiles
Attain Compliance to ICH E6 (R2)
With increasing trial complexity, growing use of CROs and fewer resources, clinical teams are challenged to meet milestones on time, within budget, and under new regulations, such as ICH E6 (R2). The Suite helps clinical operations teams with automated Quality Agreements, CRO Oversight KPIs, scorecards, and reporting to collaborate with and manage their CROs, as part of ICH E6 (R2) compliance requirements.
Speed Complex Data Reporting and Views
The new version enables end-users to configure their own personalized dashboards to help identify issues and meet study milestones, drawing on all study, system and CRO data of their choice. Access to aggregated data from disparate sources plus individualized presentation interfaces and reporting formats accelerate tasks, issue resolution, cycle time, and productivity.
Improve Speed of Medical Review
Now data managers have the ability to create custom views and in-flight reporting, add custom KPIs and investigate changes in patient data with dynamic line listings. This helps them reduce the time to discover and act on insights, adverse events and trends across disparate CROs and data sources. The Suite is built upon Comprehend’s Clinical Intelligence Platform, which allows the applications to work as a single cloud-based solution with powerful data aggregation, real-time monitoring, statistical analysis, and team collaboration capabilities.
Contact: pr@comprehend.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
